BriaCell Therapeutics annual shares outstanding
2021
2022
2023
2024
2025
BriaCell Therapeutics Shares Outstanding History (BCTX)
BriaCell Therapeutics reported 1.9M shares outstanding at the end of fiscal 2025.
View full BriaCell Therapeutics company overviewBriaCell Therapeutics annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-07-31 | 1.9M | 1.8M | +1445.36% |
| 2024 | 2024-07-31 | 121,907 | −15.9M | −99.24% |
| 2023 | 2023-07-31 | 16.0M | 463,708 | +2.99% |
| 2022 | 2022-07-31 | 15.5M | 248,435 | +1.63% |
| 2021 | 2021-07-31 | 15.3M | — | — |
BriaCell Therapeutics quarterly shares outstanding
Q4.21
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q2.25
Q3.25
Q4.25
As of Aug 31, 2025
Q2.26
Q3.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-04-30 | 7.3M | 692,395 | +10.56% |
| Q2 2026 | 2026-01-31 | 7.3M | 4.3M | +146.03% |
| As of Aug 31, 2025 | 2025-08-31 | 1.9M | −1.1M | −36.07% |
| Q4 2025 | 2025-07-31 | 1.9M | −34.3M | −94.79% |
| Q3 2025 | 2025-04-30 | 6.6M | −11.7M | −64.13% |
| Q2 2025 · Jan 31 | 2025-01-31 | 2.9M | −13.0M | −81.56% |
| Q2 2025 · Jan 24 | 2025-01-24 | 2.9M | −13.0M | −81.56% |
| Q1 2025 | 2024-10-31 | 36.2M | 20.2M | +126.40% |
| Q4 2024 | 2024-07-31 | 18.3M | 2.3M | +14.41% |
| Q3 2024 | 2024-04-30 | 16.0M | 463,408 | +2.99% |
| Q2 2024 | 2024-01-31 | 16.0M | 463,708 | +2.99% |
| Q1 2024 | 2023-10-31 | 16.0M | 463,708 | +2.99% |
| Q4 2023 | 2023-07-31 | 16.0M | 463,708 | +2.99% |
| Q3 2023 | 2023-04-30 | 15.5M | 248,735 | +1.63% |
| Q2 2023 | 2023-01-31 | 15.5M | — | — |
| Q1 2023 | 2022-10-31 | 15.5M | — | — |
| Q4 2022 | 2022-07-31 | 15.5M | — | — |
| Q4 2021 | 2021-07-31 | 15.3M | — | — |
BriaCell Therapeutics shares outstanding trends
Across the available reported history, BriaCell Therapeutics's shares outstanding moved from 121,907 to 1.9M, a change of 1.8M. The latest reported quarter, Q3 2026, shows 7.3M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BriaCell Therapeutics filings at SEC.gov ↗